Preoperative Treatment With Cetuximab and/or IMC-A12

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00957853
Recruitment Status : Completed
First Posted : August 13, 2009
Last Update Posted : August 21, 2018
ImClone LLC
Eli Lilly and Company
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 15, 2018
  Actual Study Completion Date : August 15, 2018